Skip to main content

National Pancreatic Cancer Roadmap

The National Pancreatic Cancer Roadmap (Roadmap) has been developed by Cancer Australia to improve outcomes and survival for Australians affected by pancreatic cancer.

 

The Roadmap identifies 33 key priority areas and 60 strategies for collective action over the next five years to 2027, across the continuum of pancreatic cancer care, and sets a shared agenda to drive improvements in pancreatic care, experience and outcomes.

It is for the Australian community, including people affected by pancreatic cancer, health professionals, clinical colleges, researchers, pancreatic cancer organisations, funders, peak bodies, non-government and government organisations. 

The Roadmap provides the opportunity to focus efforts on the issues that will make a significant difference to all Australians impacted by pancreatic cancer and the national collective response to the Roadmap will allow Australia to lead the world in improving outcomes and survival in pancreatic cancer. 

Background

Supporting information, context and resources.

About
The origins of the National Pancreatic Cancer Roadmap.
Roadmap development
The Roadmap adopted an evidence-based, consultative and consensus approach.

National Pancreatic Cancer Roadmap

National Pancreatic Cancer Roadmap - PDF report
Download the full PDF report.
National Pancreatic Cancer Roadmap - On a page
Download the 1 page version.

The Roadmap covers 11 domains - the seven steps in the pancreatic cancer OCP plus four additional domains that cross the whole continuum of cancer care - supportive care, research and clinical trials, data and reporting, and models of care.

Prevention and early detection
Key priority areas and strategies which focus on reducing risk, and finding pancreatic cancer early.
Presentation, initial investigations and referral
Key priorities and strategies which focus on facilitating early presentation, streamlining appropriate investigations, and supporting timely referral.
Diagnosis, staging and treatment planning
Key priority areas and strategies which focus on standardising diagnostic investigations, improving staging, and enhancing access to multidisciplinary meetings.
Treatment
Key priority areas and strategies which focus on strengthening best-practice treatment.
Care after initial treatment and recovery
Key priority areas and strategies which focus on defining and improving follow-up care.
Managing recurrent, residual or metastatic disease
Key priority areas and strategies which focus on improving management of recurrent, residual or metastatic disease.
End-of-life care
Key priority areas and strategies which focus on enhancing end-of-life care.
Supportive care
Key priority areas and strategies which focus on improving access to supportive care.
Research and clinical trials
Key priority areas and strategies which focus on undertaking collaborative research and increasing clinical trial participation.
Data and reporting
Key priority areas and strategies which focus on strengthening and increasing the use of data to improve pancreatic cancer outcomes.
Models of care
Key priority areas and strategies which focus on developing evidence-based, culturally competent models of care.
Cancer Australia

Cancer Australia was established by the Australian Government in 2006 to benefit all Australians affected by cancer, and their families and carers. Cancer Australia aims to reduce the impact of cancer, address disparities and improve outcomes for people affected by cancer by leading and coordinating national, evidence-based interventions across the continuum of care.

If you would like an interpreter to help you understand any information on this website, please call TIS National on 131 450 and ask them to call Cancer Australia on 02 9357 9400. Our business hours are 9am to 5pm, Monday to Friday.

© 2025 Cancer Australia. All rights reserved.